AzTrials
AzTrials

Intensive Care Unit Acquired WeaknessTryCYCLENCT01885442

TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients

A study testing In-bed leg cycle ergometry in people with Intensive Care Unit Acquired Weakness and Critical Care, run by McMaster University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very vulnerable to weakness and disability. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
In-bed leg cycle ergometry
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteCanada
Study dates
Sep 2013to Jan 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients ≥18 years old
  • Invasively mechanically ventilated ≤4 days
  • Expected additional 2 day ICU stay
  • Ability to ambulate independently pre-hospital (with or without a gait aid)

Who cannot join

  • Unable to follow simple commands at baseline
  • Pregnancy
  • Acute conditions impairing ability to walk or cycle (e.g., leg or foot fracture)
  • Acute central condition or peripheral injury resulting in neuromuscular weakness (e.g., stroke, Guillain Barré syndrome)
  • Primary generalized weakness of the central or peripheral nervous system (e.g., multiple sclerosis, myasthenia gravis, Parkinson's disease, amyotrophic lateral sclerosis)
  • Temporary pacemaker wires
Show all 12Show fewer
  • Expected hospital mortality> 90%
  • Cycling equipment unable to fit patient's body dimensions (e.g., leg amputation or obesity)
  • Specific surgical exclusion as stipulated by attending
  • ->7 day ICU stay
  • Physician declines
  • Patient did not meet daily screening criteria to provide in-bed leg cycling during the first 4 days of mechanical ventilation

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • St. Joseph's Healthcare Intensive Care Unit

    Hamilton, Ontario, L8N 4A6

Other trials in Canada

About this study

Official title: TryCYCLE (Critical Care Cycling to Improve Lower Extremity Strength): A Prospective Pilot Study of the Safety and Feasibility of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very vulnerable to weakness and disability. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. In-bed cycling employs special equipment that attaches to a patient's hospital bed, allowing them gentle leg exercise while in the ICU. The investigators will offer patients in-bed cycling while they are needing a breathing machine, to help them recover from weakness as fast as possible. Before doing a larger trial testing if in-bed cycling reduces disability, data on safety (Is it safe?) and feasibility (Can the investigators do it?) are needed.

Objectives: To study the safety and feasibility of in-bed leg cycling in critically ill patients who need breathing machines.

Read more

Methods: Adult patients admitted to the ICU who need a breathing machine and are expected to survive their ICU stay are eligible. Specially trained physiotherapists will provide patients with 30 minutes of in-bed cycling each day while they are in the ICU.

Outcomes: The investigators will study (1) Safety: the heart rate and breathing patterns of patients doing in-bed cycling, while carefully monitoring for safety. (2) Feasibility: whether patients can cycle on most days of their ICU stay, whether patients and their families agree to be a part of the study, and whether the investigators can assess patients' strength in the ICU and at hospital discharge.

Relevance: As the Canadian population ages, the demand for breathing machines during acute illness will increase dramatically. Effective methods of physiotherapy are needed for critically ill patients to minimize muscle weakness, speed recovery, and improve quality of life. This pilot study is the first of several future larger studies about in-bed cycling in the ICU. This program of research will help patients needing life support to regain their strength and recover as fast as possible from critical illness.

Being tested
In-bed leg cycle ergometry
Keywords
mechanical ventilation, cycle ergometry, intensive care unit, rehabilitation
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In-bed leg cycle ergometryDevice

    Also called RT300 Supine Cycle Ergometer (Restorative Therapies, Baltimore, MD)

    Patients will receive 30 minutes of in-bed leg cycling in addition to routine physiotherapy, 6 days per week, for the duration of their ICU stay (to a maximum of 28 days).

Study groups in NCT01885442
Study groupRoleWhat they receive
In-bed leg cycle ergometryExperimentalNot described
Receives: Device: In-bed leg cycle ergometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of in-bed leg cycling research sessions terminated (composite outcome)

    Research sessions will stop if the patient meets any of the following criteria:

    • Sustained oxygen desaturation <88%, despite adjustments to FiO2
    • Heart rate
    • Low: 20 bpm less than lowest baseline value or 40 bpm (whichever is highest)
    • High: 20 bpm more than highest baseline value or 140 bpm (whichever is lowest)
    • Mean Arterial Pressure <55 or >110 mmHg
    • Marked ventilator dyssynchrony not corrected by adjusting cycle off criteria

    Safety events:

    • Suspected new unstable / uncontrolled arrhythmia
    • Concern for myocardial ischaemia
    • Respiratory distress leading to symptoms of intolerable dyspnea
    • Unplanned extubation Any of the following catheter or tube dislodgements
    • Catheters: Central venous, arterial, dialysis, or pulmonary artery catheter
    • Tubes: Orogastric, nasogastric, or percutaneous endoscopic gastrostomy

    ICU physician, patient or proxy requests termination of session

    Measured: From date of enrollment until date of ICU discharge, approximately 10 days on average

Secondary outcomes (6)
  1. Number of adverse events: Intravascular catheter or tube dislodgement rate during in-bed cycling

    Any of the following catheter or tube dislodgements:

    • Catheters: Central venous, arterial, dialysis, or pulmonary artery catheter
    • Tubes: Orogastric, nasogastric, or percutaneous endoscopic gastrostomy

    Measured: From date of enrollment until date of ICU discharge, approximately 10 days on average

  2. Daily research session delivery rate

    We will assess our ability to deliver cycling during the ICU stay by comparing our daily delivery rate with that achieved in ICU rehabilitation randomized clinical trials (80%).

    Measured: From date of enrollment until date of ICU discharge, approximately 10 days on average

  3. Rate of outcome measure ascertainment in assessable patients at ICU awakening

    We will calculate the binary proportion and 95% confidence interval for outcome measure ascertainment event rates.

    Measured: 5 days after study admission, on average

  4. Rate of outcome measure ascertainment in assessable patients at ICU discharge

    We will calculate the binary proportion and 95% confidence interval for outcome measure ascertainment event rates.

    Measured: 10 days after study admission, on average

  5. Rate of outcome measure ascertainment in assessable patients at hospital discharge

    We will calculate the binary proportion and 95% confidence interval for outcome measure ascertainment event rates.

    Measured: 15 days after study admission, on average

  6. Consent rate feasibility

    Consent rate

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2013 (estimated)
  2. Study startSep 2013
  3. Primary completionSep 2014
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01885442
Sponsor's protocol ID
TryCYCLE
Acronym
TryCYCLE
Status last verified
Apr 2016
First submitted
21 Mar 2013
Last updated
6 Apr 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Kho ME, Molloy AJ, McCaughan M, et al. TryCYCLE: Preliminary results of early in-bed cycling with mechanically ventilated patients. Crit Care Med 2014;43.

  • Kho ME, Molloy AJ, Clarke FJ, Ajami D, McCaughan M, Obrovac K, Murphy C, Camposilvan L, Herridge MS, Koo KK, Rudkowski J, Seely AJ, Zanni JM, Mourtzakis M, Piraino T, Cook DJ; Canadian Critical Care Trials Group. TryCYCLE: A Prospective Study of the Safety and Feasibility of Early In-Bed Cycling in Mechanically Ventilated Patients. PLoS One. 2016 Dec 28;11(12):e0167561. doi: 10.1371/journal.pone.0167561. eCollection 2016.

    PubMed 28030555

Questions about this trial

What is this clinical trial studying?

A study testing In-bed leg cycle ergometry in people with Intensive Care Unit Acquired Weakness and Critical Care, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of in-bed leg cycling research sessions terminated (composite outcome) (time frame: From date of enrollment until date of ICU discharge, approximately 10 days on average). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01885442, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in